SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-20-313916
Filing Date
2020-12-09
Accepted
2020-12-09 17:11:20
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 d10551d424b3.htm 424B3 28342
2 GRAPHIC g10551g64f96.jpg GRAPHIC 5765
  Complete submission text file 0001193125-20-313916.txt   37530
Mailing Address 131 DARTMOUTH STREET SUITE 502 BOSTON MA 02116
Business Address 131 DARTMOUTH STREET SUITE 502 BOSTON MA 02116 844-304-2048
Cerevel Therapeutics Holdings, Inc. (Filer) CIK: 0001805387 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-250964 | Film No.: 201378539
SIC: 2834 Pharmaceutical Preparations